Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hepatoblastoma × sintilimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 43 Stomach Neoplasms 35 Carcinoma, Non-Small-Cell Lung 27 Colorectal Neoplasms 17 Esophageal Squamous Cell Carcinoma 13 Nasopharyngeal Carcinoma 10 Lung Neoplasms 10 Rectal Neoplasms 8 Pancreatic Neoplasms 7 Esophageal Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Liver Neoplasms 5 Cholangiocarcinoma 5 Neoplasms 4 Triple Negative Breast Neoplasms 3 Recurrence 3 Lymphoma, Extranodal NK-T-Cell 3 Colorectal Cancer Metastatic 3 Carcinoma, Renal Cell 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Turcot syndrome 2 Thyroid Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Nonsquamous Non-Small Cell Lung Cancer 2 Neuroendocrine Tumors 2 Neoplasm Metastasis 2 Locally Advanced Rectal Cancer 2 Glioblastoma 2

Interventions

Cyclophosphamide 6 Granulocyte Colony-Stimulating Factor 5 Melphalan 4 Etoposide 4 Cisplatin 4 Carboplatin 4 sodium thiosulfate 3 fludarabine 3 Thiotepa 3 Mesna 3 Filgrastim 3 Busulfan 3 pembrolizumab 2 Vorinostat 2 Vincristine 2 Peripheral Blood Stem Cell Transplantation 2 Nivolumab 2 Ifosfamide 2 Gemcitabine 2 Fluorouracil 2 Doxorubicin 2 talazoparib 1 sintilimab 1 sargramostim 1 pegylated granulocyte colony-stimulating factor 1 omburtamab I-131 1 lenvatinib 1 irinotecan sucrosofate 1 fludarabine phosphate 1 etoposide phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05322187 2022-04-11

sPLENTY-pc

RenJi Hospital

Phase 2/3 Unknown

Gastrointestinal

Liver Neoplasms, Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡